Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02564263 |
|---|---|
| Brief Title: | Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181) |
| First Submitted : | September 29, 2015 |
| First Submitted that Met QC Criteria : | September 29, 2015 |
| First Posted : | September 30, 2015 (Estimate) |
| Results First Submitted : | September 26, 2019 |
| Results First Submitted that Met QC Criteria : | November 1, 2019 |
| Results First Posted : | November 20, 2019 |
| Last Update Submitted that Met QC Criteria : | February 9, 2023 |
| Last Update Posted : | March 13, 2023 |